Scalper1 News
Specialty drugmaker Forest Laboratories (FRX) agreed to pay $1.1 billion in cash for smaller counterpart Furiex Pharmaceuticals (FURX) Monday, sending the latter’s stock up more than 30% in midday trading on the stock market today. Forest, which is itself in the process of being bought by Actavis (ACT), will pay $95 a share, a 19% premium to Friday’s closing price. Forest also agreed to pay up to $30 a share, or $360 million, depending on how Scalper1 News
Scalper1 News